Merck & Co. (MRK)
(Delayed Data from NYSE)
$85.98 USD
-0.30 (-0.35%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $86.10 +0.12 (0.14%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum B VGM
Key Expected Earnings Data
| Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
|---|---|---|---|
| 02/03/2026
Time: -- |
12/2025 | $2.17 | 0.28% |
Earnings Summary
For their last quarter, Merck & Co. (MRK) reported earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.36 per share. This reflects a positive earnings surprise of 9.32%. Look out for MRK's next earnings release expected on February 03, 2026. For the next earning release, we expect the company to report earnings of $2.17 per share, reflecting a year-over-year increase of 26.16%.
Earnings History
Price & Consensus
Zacks News for MRK
Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Buy, Sell or Hold MRK Stock Ahead of Q3 Earnings? Things to Know
MRK FAQs
Merck & Co., Inc. (MRK) has announced they will report their next quarter earnings on February 03, 2026. For the next earning release, we expect the company to report earnings of $2.17 per share, reflecting a year-over-year increase of 26.16%.
Merck & Co., Inc. has announced they will report their previous quarter earnings after the close of the market on February 03, 2026.
The Zacks Consensus Estimate for Merck & Co., Inc. (MRK) for the quarter ending in December 2025 is $2.17 a share. We expect Merck & Co., Inc. to miss by 0.28%.
In the earnings report for the quarter ending in September 2024, Merck & Co., Inc. (MRK) announced earnings of $1.57 per share versus the Zacks Consensus Estimate of $1.50 per share, representing a surprise of 4.67%.
